News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
325,311 Results
Type
Article (17678)
Company Profile (305)
Press Release (307323)
Multimedia
Podcasts (73)
Webinars (12)
Section
Business (95336)
Career Advice (215)
Deals (16777)
Drug Delivery (46)
Drug Development (57206)
Employer Resources (41)
FDA (6795)
Job Trends (6454)
News (171222)
Policy (11987)
Tag
Academia (996)
Accelerated approval (10)
Adcomms (14)
Allergies (72)
Alliances (24658)
ALS (111)
Alzheimer's disease (1072)
Antibody-drug conjugate (ADC) (193)
Approvals (6914)
Artificial intelligence (219)
Autoimmune disease (65)
Automation (10)
Bankruptcy (121)
Best Places to Work (5558)
BIOSECURE Act (7)
Biosimilars (96)
Biotechnology (239)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (311)
Cancer (2829)
Cardiovascular disease (215)
Career advice (195)
Career pathing (7)
CAR-T (194)
CDC (6)
Cell therapy (520)
Cervical cancer (16)
Clinical research (48402)
Collaboration (960)
Company closure (3)
Compensation (584)
Complete response letters (32)
COVID-19 (1224)
CRISPR (76)
C-suite (419)
Cystic fibrosis (116)
Data (3519)
Decentralized trials (1)
Denatured (13)
Depression (75)
Diabetes (250)
Diagnostics (2067)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (156)
Drug pricing (47)
Drug shortages (5)
Duchenne muscular dystrophy (186)
Earnings (39686)
Editorial (22)
Employer branding (8)
Employer resources (38)
Events (59545)
Executive appointments (649)
FDA (8346)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (856)
Gene editing (159)
Generative AI (18)
Gene therapy (428)
GLP-1 (566)
Government (1277)
Grass and pollen (2)
Guidances (206)
Healthcare (7735)
HIV (23)
Huntington's disease (35)
IgA nephropathy (61)
Immunology and inflammation (177)
Immuno-oncology (11)
Indications (39)
Infectious disease (1346)
Inflammatory bowel disease (147)
Inflation Reduction Act (10)
Influenza (45)
Intellectual property (139)
Interviews (23)
IPO (9025)
IRA (21)
Job creations (1228)
Job search strategy (175)
Kidney cancer (9)
Labor market (23)
Layoffs (355)
Leadership (12)
Legal (1729)
Liver cancer (53)
Longevity (8)
Lung cancer (413)
Lymphoma (205)
Machine learning (21)
Management (11)
Manufacturing (324)
MASH (118)
Medical device (3197)
Medtech (3206)
Mergers & acquisitions (8359)
Metabolic disorders (700)
Multiple sclerosis (104)
NASH (14)
Neurodegenerative disease (158)
Neuropsychiatric disorders (53)
Neuroscience (1856)
NextGen: Class of 2025 (2313)
Non-profit (982)
Now hiring (28)
Obesity (324)
Opinion (142)
Ovarian cancer (121)
Pain (88)
Pancreatic cancer (126)
Parkinson's disease (190)
Partnered (12)
Patents (280)
Patient recruitment (236)
Peanut (42)
People (30167)
Pharmaceutical (52)
Pharmacy benefit managers (7)
Phase I (16707)
Phase II (22340)
Phase III (14759)
Pipeline (2102)
Policy (94)
Postmarket research (960)
Preclinical (6926)
Press Release (32)
Prostate cancer (134)
Psychedelics (48)
Radiopharmaceuticals (254)
Rare diseases (514)
Real estate (1772)
Recruiting (17)
Regulatory (11036)
Reports (20)
Research institute (1035)
Resumes & cover letters (25)
Rett syndrome (13)
RNA editing (15)
RSV (28)
Schizophrenia (116)
Series A (158)
Series B (112)
Service/supplier (2)
Sickle cell disease (69)
Special edition (16)
Spinal muscular atrophy (122)
Sponsored (14)
Startups (2227)
State (1)
Stomach cancer (5)
Supply chain (35)
Tariffs (25)
The Weekly (59)
Vaccines (437)
Venture capital (52)
Weight loss (186)
Women's health (28)
Worklife (2)
Date
Last 7 days (488)
Last 30 days (1619)
Last 365 days (21209)
2025 (17081)
2024 (23717)
2023 (26007)
2022 (31456)
2021 (32380)
2020 (27256)
2019 (19206)
2018 (14147)
2017 (16684)
2016 (14150)
2015 (17049)
2014 (12164)
2013 (8702)
2012 (8919)
2011 (9166)
2010 (8903)
Location
Africa (200)
Alabama (61)
Alaska (2)
Arizona (69)
Arkansas (5)
Asia (21476)
Australia (3691)
California (6656)
Canada (1764)
China (685)
Colorado (214)
Connecticut (264)
Delaware (196)
Europe (47040)
Florida (811)
Georgia (204)
Hawaii (2)
Idaho (18)
Illinois (362)
India (26)
Indiana (187)
Iowa (9)
Japan (223)
Kansas (75)
Kentucky (7)
Louisiana (4)
Maine (11)
Maryland (758)
Massachusetts (5230)
Michigan (105)
Minnesota (226)
Mississippi (3)
Missouri (37)
Montana (16)
Nebraska (4)
Nevada (35)
New Hampshire (16)
New Jersey (1768)
New Mexico (15)
New York (1727)
North Carolina (793)
North Dakota (6)
Northern California (3189)
Ohio (161)
Oklahoma (13)
Oregon (23)
Pennsylvania (1197)
Puerto Rico (10)
Rhode Island (26)
South America (275)
South Carolina (8)
Southern California (2538)
Tennessee (41)
Texas (853)
United States (22336)
Utah (110)
Virginia (140)
Washington D.C. (43)
Washington State (535)
West Virginia (1)
Wisconsin (60)
325,311 Results for "pipeline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
October 23, 2025
·
5 min read
Press Releases
Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline
October 1, 2025
·
6 min read
Press Releases
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
October 22, 2025
·
11 min read
Press Releases
Valink Therapeutics Closes $11.8 Million Pre-A Financing Round to Advance Oncology Pipeline
October 21, 2025
·
3 min read
Immunology and inflammation
Lupus Reveal Gives Investors a Peek at Biogen’s ‘Underappreciated’ Pipeline
With two late-stage programs set to read out in the next 48 months, Biogen is translating its wealth of experience in multiple sclerosis to lupus—developing a pipeline BMO Capital Markets analysts called “thoughtful.”
September 9, 2025
·
4 min read
·
Heather McKenzie
Press Releases
Enhanced Genomics Extends Series A Funding to USD $19 Million to Drive Development of Therapeutics Pipeline
September 17, 2025
·
2 min read
Press Releases
MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development
September 18, 2025
·
5 min read
Press Releases
Oncotelic Therapeutics Highlights 2 Years of Clinical and Regulatory Advancements Across Late-Stage Pipeline
September 15, 2025
·
4 min read
Press Releases
Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025
September 18, 2025
·
6 min read
Press Releases
Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity
October 15, 2025
·
4 min read
1 of 32,532
Next
